Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Total Liabilities (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Total Liabilities for 16 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities fell 30.06% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 30.06% decrease, with the full-year FY2024 number at $3.1 million, down 11.72% from a year prior.
  • Total Liabilities was $1.8 million for Q3 2025 at GeoVax Labs, down from $2.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.4 million in Q4 2021 to a low of $335650.0 in Q3 2021.
  • A 5-year average of $3.8 million and a median of $3.5 million in 2023 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: crashed 87.21% in 2021, then skyrocketed 1922.76% in 2022.
  • GeoVax Labs' Total Liabilities stood at $7.4 million in 2021, then plummeted by 36.14% to $4.7 million in 2022, then fell by 25.86% to $3.5 million in 2023, then dropped by 11.72% to $3.1 million in 2024, then tumbled by 41.29% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Total Liabilities are $1.8 million (Q3 2025), $2.5 million (Q2 2025), and $2.9 million (Q1 2025).